4 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 4 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accessing Mobility Using Wearable Sensors Exercise - COPD, Pulmonary Disease | Phase 1 / Phase 2 | Withdrawn | Baylor College of Medicine | 2018-05-21 | 2025-08-27 | |
| A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge Active (PF-03526299), Placebo - Asthma | Phase 1 | Withdrawn | Pfizer | 2011-02-01 | 2011-12-02 | |
| Study Evaluating Single Doses of GAP-134 active, placebo - Healthy Subjects | Phase 1 | Withdrawn | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-02-01 | 2018-09-27 | |
| Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or Overweight physical activity - Inflammation | Phase 1 | Withdrawn | Copenhagen University Hospital, Rigshospitalet | 280 | 2006-03-01 | 2007-08-21 |
Asthma (1) · Cardiovascular Diseases (1) · Heart Failure (1) · Inflammation (1) · Lung Diseases (1) · Pulmonary Disease, Chronic Obstructive (1)
Baylor College of Medicine (1) · Copenhagen University Hospital, Rigshospitalet (1) · Pfizer (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Denmark (1) · United States (1)
Bettina Breitowicz, MD (1) · Bijan Najafi, PhD (1)